Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: A prospective, monocentre trial on 199 patients

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL. 70, 2012, Pages

  Kostianovsky, Alex ^a,c   Charles, Pierre ^a   Alves, Jean Françoi ^a   Goulet, Michèle ^a   Pagnoux, Christian ^a   Le Guern, Véronique ^a   Mouthon, Luc ^a   Krivine, Anne ^a   Villiger, Peter ^a,b   Launay, Odile ^a   Guillevin, Loïc ^a  

^a Université Paris Descartes ^*  (France)

^b UNIVERSITY OF BERN   (Switzerland)

^c CEMIC   (Argentina)

Author keywords

Anti CD20; Flu; Immunosuppressants; Lupus; Sj gren's syndrome; Systemic sclerosis; Vaccination; Vasculitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; INFLUENZA VACCINE; METHOTREXATE; MYCOPHENOLIC ACID; RITUXIMAB; TACROLIMUS;

2009 H1N1 INFLUENZA; ADULT; AGED; APPLICATION SITE PAIN; APPLICATION SITE REACTION; APPLICATION SITE REDNESS; APPLICATION SITE SWELLING; ARTICLE; AUTOIMMUNE DISEASE; CHILL; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; NECROTIZING ARTERITIS; PANDEMIC INFLUENZA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEASONAL INFLUENZA; SEROCONVERSION; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VACCINATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; AUTOIMMUNE DISEASES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LINEAR MODELS; MALE; MIDDLE AGED; PANDEMICS; PARIS; PATIENT SAFETY; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEASONS; TIME FACTORS; YOUNG ADULT;

EID: 84863755173     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. DAWOOD FS, JAIN S, FINELLI L et al.: Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360: 2605-15.
2. CHOWELL G, BERTOZZI SM, COLCHERO MA et al.: Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009; 361: 674-9.
3. ZAFRIR Y, AGMON-LEVIN N, SHOENFELD Y: Post-influenza vaccination vasculitides: a possible new entity. J Clin Rheumatol 2009; 15: 269-70.
4. POU MA, DIAZ-TORNE C, VIDAL S et al.: Development of autoimmune diseases after vaccination. J Clin Rheumatol 2008; 14: 243-4.
5. VANOLI M, GAMBINI D, SCORZA R: A case of Churg-Strauss vasculitis after hepatitis B vaccination. Ann Rheum Dis 1998; 57: 256-7.
6. BIRCK R, KAELSCH I, SCHNUELLE P, FLORES-SUAREZ LF, NOWACK R: ANCAassociated vasculitis following influenza vaccination: causal association or mere coincidence? J Clin Rheumatol 2009; 15: 289-91
7. LU CC, WANG YC, LAI JH, LEE TS, LIN HT, CHANG DM: A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine 2011; 29: 444-50.
8. VITALI C, BOMBARDIERI S, JONSSON R et al.: Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
9. SCHATTNER A: Consequence or coincidence? The occurrance, pathogenesis and significance of autoimmmune manifestations after viral vaccines. Vaccine 2005; 23: 3876-86.
10. ELIAKIM M, SLAVIN S, ZLOTNICK A: Chronic liver disease associated with mixed cryoglobulinemia. Review of the literature and presentation of two cases. Med Chir Dig 1972; 1: 67-72.
11. GOCKE D, HSU K, MORGAN C, BOMBARDIERI S, LOCKSHIN M, CHRISTIAN C: Association between polyarteritis and Australia antigen. Lancet 1970; 2: 1149-53.
12. AGMON-LEVIN N, PAZ Z, ISRAELI E, SHOENFELD Y: Vaccines and autoimmunity. Nat Rev Rheumatol 2009; 5: 648-52.
13. CLARKE AJ, GULATI P, ABRAHAM SM: A cross-sectional audit of the uptake of seasonal and H1N1 influenza vaccination among patients with rheumatoid arthritis in a London hospital. Clin Exp Rheumatol 2011; 29: 596.
14. STASSEN P, SANDERS J, KALLENBERG C, STEGEMAN C: Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2008; 23: 654-8.
15. ISRAELI E, AGMON-LEVIN N, BLANK M, SHOENFELD Y: Adjuvants and autoimmunity. Lupus 2009; 18: 1217-25.
16. LITINSKY I, BALBIR A, ZISMAN D et al.: Vaccination against influenza in patients with systemic sclerosis. Clin Exp Rheumatol 2012 Mar 9. [Epub ahead of print]
17. GUILLEVIN L, PAGNOUX C, MOUTHON L: Churg-Strauss syndrome. Semin Respir Crit Care Med 2004; 25: 535-45.
18. BOURNIA VK, SFONTOURIS C, KONSTA M, ILIOPOULOS A: H1N1 influenza outcome in rheumatic patients under biological therapy. Clin Exp Rheumatol 2012 Feb 28. [Epub ahead of print].